Yueyin Pan Selected Research

Yueyin Pan Research Topics

Disease

44	Neoplasms (Cancer) 05/2024 - 03/2009
29	Breast Neoplasms (Breast Cancer) 02/2024 - 03/2014
17	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 09/2011
13	Disease Progression 12/2023 - 01/2018
12	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2020
6	Triple Negative Breast Neoplasms 01/2024 - 11/2014
4	Esophageal Squamous Cell Carcinoma 02/2024 - 01/2022
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 01/2021
3	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2011
2	Hypoxia (Hypoxemia) 01/2024 - 07/2022
2	Inflammation (Inflammations) 10/2023 - 06/2021
2	Neutropenia 01/2023 - 11/2021
2	Body Weight (Weight, Body) 01/2023 - 01/2021
2	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 07/2019
2	Leukopenia 01/2023 - 11/2021
2	Carcinogenesis 04/2021 - 01/2021
2	Lymphatic Metastasis 10/2020 - 10/2019
2	Esophageal Neoplasms (Esophageal Cancer) 01/2018 - 01/2017
2	Stomach Neoplasms (Stomach Cancer) 01/2018 - 01/2018
2	Nausea 07/2017 - 03/2009
1	Hypokalemia 02/2024
1	Proteinuria 02/2024
1	Hypertension (High Blood Pressure) 02/2024
1	Adenocarcinoma 12/2023
1	Anemia 12/2023
1	Adenocarcinoma of Lung 12/2023
1	Respiratory Insufficiency (Respiratory Failure) 01/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Pulmonary Tuberculosis 01/2023

Drug/Important Bio-Agent (IBA)

10	Hormones (Hormone)IBA 02/2024 - 11/2014
9	camrelizumabIBA 05/2024 - 01/2021
9	Biomarkers (Surrogate Marker)IBA 12/2023 - 07/2019
8	Tyrosine Kinase InhibitorsIBA 12/2023 - 11/2016
7	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 01/2018
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2024 - 01/2018
5	Estrogen ReceptorsIBA 02/2024 - 07/2015
5	PlatinumIBA 12/2023 - 01/2021
5	sintilimabIBA 12/2023 - 01/2022
4	RNA (Ribonucleic Acid)IBA 12/2023 - 01/2017
4	apatinibIBA 12/2023 - 11/2014
3	Immune Checkpoint InhibitorsIBA 05/2024 - 12/2023
3	ErbB Receptors (EGF Receptor)IBA 01/2024 - 06/2017
3	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2022
3	Pemetrexed (MTA)FDA Link 01/2023 - 01/2021
3	Bevacizumab (Avastin)FDA Link 01/2023 - 12/2021
3	Capecitabine (Xeloda)FDA Link 01/2023 - 11/2014
3	Trastuzumab (Herceptin)FDA Link 01/2023 - 01/2020
3	exemestane (Aromasin)FDA Link 12/2022 - 07/2015
3	LigandsIBA 12/2022 - 01/2022
3	Monoclonal AntibodiesIBA 01/2022 - 01/2017
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2024 - 02/2024
2	famitinibIBA 05/2024 - 02/2024
2	Angiogenesis InhibitorsIBA 05/2024 - 12/2023
2	Progesterone Receptors (Progesterone Receptor)IBA 02/2024 - 01/2024
2	Carboplatin (JM8)FDA LinkGeneric 01/2024 - 01/2021
2	130-nm albumin-bound paclitaxelIBA 01/2024 - 12/2022
2	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 12/2023 - 01/2020
2	pyrotinibIBA 10/2023 - 01/2023
2	osimertinibIBA 03/2023 - 12/2020
2	rezivertinibIBA 01/2023 - 11/2022
2	dalpiciclibIBA 01/2023 - 11/2021
2	Biosimilar PharmaceuticalsIBA 01/2023 - 01/2022
2	niraparibIBA 01/2023 - 01/2021
2	Tamoxifen FDA LinkGeneric 01/2023 - 12/2022
2	human ERBB2 proteinIBA 01/2023 - 01/2022
2	Fulvestrant (Faslodex)FDA Link 01/2023 - 11/2021
2	Gemcitabine FDA Link 12/2022 - 01/2022
2	Programmed Cell Death 1 ReceptorIBA 04/2022 - 01/2022
2	Docetaxel (Taxotere)FDA Link 05/2021 - 09/2011
2	MicroRNAs (MicroRNA)IBA 05/2021 - 01/2017
2	IntegrinsIBA 04/2021 - 12/2020
2	AnthracyclinesIBA 01/2021 - 11/2014
2	Phosphotransferases (Kinase)IBA 01/2020 - 07/2015
2	ORALIT (ORS)IBA 10/2019 - 07/2019
2	Gefitinib (Iressa)FDA Link 06/2017 - 11/2016
1	Alanine Transaminase (SGPT)IBA 02/2024
1	sugemalimabIBA 02/2024
1	penpulimabIBA 01/2024
1	BiglycanIBA 01/2024
1	toripalimabIBA 01/2024
1	SerpinsIBA 01/2024
1	Interleukin-3 (Interleukin 3)IBA 01/2024
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 12/2023
1	pemigatinibIBA 12/2023
1	icotinibIBA 10/2023
1	palbociclibIBA 09/2023
1	Circular RNAIBA 03/2023
1	Letrozole (Femara)FDA LinkGeneric 01/2023
1	HMPL-013IBA 01/2023
1	Anastrozole (Arimidex)FDA LinkGeneric 01/2023
1	Interleukin-8 (Interleukin 8)IBA 01/2023
1	ElectrolytesIBA 01/2023
1	Estrogens (Estrogen)FDA Link 01/2023
1	sacituzumab govitecanIBA 01/2023

Therapy/Procedure

30	Drug Therapy (Chemotherapy) 02/2024 - 01/2008
23	Therapeutics 12/2023 - 01/2017
8	Neoadjuvant Therapy 02/2024 - 01/2021
5	Immunotherapy 12/2023 - 01/2021
2	Photothermal Therapy 01/2022 - 01/2022
1	Chemoradiotherapy 01/2024